Enrolling by invitationPhase 3NCT06475742

Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus

Studying Autosomal systemic lupus erythematosus

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Viatris Innovation GmbH
Principal Investigator: Clinical Trials
Viatris Innovation GmbH
Intervention: Cenerimod(drug)
Enrollment: 680 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2024 – 2028

Study locations (30)

Clinical Research of West Florida, Inc., Clearwater, Florida, United States
Omega Research MetroWest, LLC, DeBary, Florida, United States
SouthCoast Research Center, Inc., Miami, Florida, United States
Allied Biomedical Research Institute, Miami, Florida, United States
D&H National Research Centers INC, Miami, Florida, United States
San Marcus Res Clin Inc., Miami Lakes, Florida, United States
Accurate Clinical Research Inc. - Lake Charles, Lake Charles, Louisiana, United States
RB Wellness Clinic, Las Vegas, Nevada, United States
Accurate Clinical Research Inc - (Najam), Baytown, Texas, United States
Novel Research LLC, Bellaire, Texas, United States
Accurate Clinical Research Inc., Houston, Texas, United States
Aprillus Asistencia e Investigacion, Buenos Aires, Argentina
Centro Médico Arsema, Buenos Aires, Argentina
Fundación Respirar, Buenos Aires, Argentina
IR Medical Center S.A., Mendoza, Argentina
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06475742 on ClinicalTrials.gov

Other trials for Autosomal systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Autosomal systemic lupus erythematosus →

← Back to all trials